115 related articles for article (PubMed ID: 7830708)
1. [Study on the expression of oncogene mRNA in hepatocellular carcinoma using in situ hybridization technique].
Hayashi D
Nihon Geka Gakkai Zasshi; 1994 Nov; 95(11):814-22. PubMed ID: 7830708
[TBL] [Abstract][Full Text] [Related]
2. [Overexpression of c-myc and p53 gene in human hepato-cellular carcinoma--a study with immunohistochemistry and in situ hybridization].
Yang S; Wang M; You W
Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):415-7. PubMed ID: 8697990
[TBL] [Abstract][Full Text] [Related]
3. Expression of ras and c-myc oncoproteins and hepatitis B surface antigen in human liver disease.
Tiniakos D; Spandidos DA; Yiagnisis M; Tiniakos G
Hepatogastroenterology; 1993 Feb; 40(1):37-40. PubMed ID: 8462926
[TBL] [Abstract][Full Text] [Related]
4. The potential role of bcl-2 mRNA and protein exression in hepatocellular carcinomas.
Ravazoula P; Tsamandas AC; Kardamakis D; Gogos C; Karatza C; Thomopoulos K; Tepetes K; Kourelis T; Petsas T; Bonikos DS; Karavias D
Anticancer Res; 2002; 22(3):1799-805. PubMed ID: 12168872
[TBL] [Abstract][Full Text] [Related]
5. Expression of ras and myc oncogenes in human hepatocellular carcinoma and non-neoplastic liver tissues.
Tiniakos D; Spandidos DA; Kakkanas A; Pintzas A; Pollice L; Tiniakos G
Anticancer Res; 1989; 9(3):715-21. PubMed ID: 2548435
[TBL] [Abstract][Full Text] [Related]
6. Distribution of oval cells and c-myc mRNA expression in mouse hepatocarcinogenesis.
Fang CH; Zhang GQ; Zhu XY; Gong JQ
Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):433-9. PubMed ID: 15313684
[TBL] [Abstract][Full Text] [Related]
7. High-throughput tissue microarray analysis of c-myc activation in chronic liver diseases and hepatocellular carcinoma.
Chan KL; Guan XY; Ng IO
Hum Pathol; 2004 Nov; 35(11):1324-31. PubMed ID: 15668888
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of c-myc gene without gene amplification in human hepatocellular carcinoma.
Wu B; Wang M; You W; Yang S
Chin Med J (Engl); 1996 Dec; 109(12):922-5. PubMed ID: 9275322
[TBL] [Abstract][Full Text] [Related]
9. The expression of c-myc and c-N-ras in human cirrhotic livers, hepatocellular carcinomas and liver tissue surrounding the tumors.
Zhang XK; Huang DP; Qiu DK; Chiu JF
Oncogene; 1990 Jun; 5(6):909-14. PubMed ID: 2163054
[TBL] [Abstract][Full Text] [Related]
10. [Expression of telomerase reverse transcriptase and its relationship with tumor suppressor gene p53 in HCC].
Dai D; Zhai W; Zhu T; Zhu H; Ling Y
Zhonghua Gan Zang Bing Za Zhi; 2001 Jul; 9 Suppl():79-81. PubMed ID: 11509149
[TBL] [Abstract][Full Text] [Related]
11. [Comparative study of expression of p21 and c-myc protein in hepatocellular carcinoma with pericarcinomatous liver tissue].
Feng D; Cheng R; Yan Y
Hunan Yi Ke Da Xue Xue Bao; 1997; 22(4):310-2. PubMed ID: 9868083
[TBL] [Abstract][Full Text] [Related]
12. Expression of alpha-fetoprotein and albumin genes in human hepatocellular carcinomas: limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy.
Ohguchi S; Nakatsukasa H; Higashi T; Ashida K; Nouso K; Ishizaki M; Hino N; Kobayashi Y; Uematsu S; Tsuji T
Hepatology; 1998 Feb; 27(2):599-607. PubMed ID: 9462663
[TBL] [Abstract][Full Text] [Related]
13. [Albumin mRNA and pCEA in the histopathologic diagnosis of hepatocellular carcinoma].
Foschini MP; Macchia S; Baccarini P; Milandri GL; Losi L; Spongano P; Panarelli M; Dal Monte PR; Eusebi V
Pathologica; 1999 Aug; 91(4):260-7. PubMed ID: 10630075
[TBL] [Abstract][Full Text] [Related]
14. Identification of c-Yes expression in the nuclei of hepatocellular carcinoma cells: involvement in the early stages of hepatocarcinogenesis.
Nonomura T; Masaki T; Morishita A; Jian G; Uchida N; Himoto T; Izuishi K; Iwama H; Yoshiji H; Watanabe S; Kurokohchi K; Kuriyama S
Int J Oncol; 2007 Jan; 30(1):105-11. PubMed ID: 17143518
[TBL] [Abstract][Full Text] [Related]
15. [Expressions of h-TERT, c-myc, PCNA and cell apoptosis in liver carcinogenesis].
Fu XM; Yang QX; Shao CK; Feng ZY
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):821-3. PubMed ID: 16793609
[TBL] [Abstract][Full Text] [Related]
16. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
Dong-Dong L; Xi-Ran Z
Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
[TBL] [Abstract][Full Text] [Related]
17. Alterations of the fragile histidine triad gene in hepatitis C virus-associated hepatocellular carcinoma.
Zekri AR; Bahnassy AA; Hafez M; El-Shehaby AM; Sherif GM; Khaled HM; Zakhary N
J Gastroenterol Hepatol; 2005 Jan; 20(1):87-94. PubMed ID: 15610452
[TBL] [Abstract][Full Text] [Related]
18. Osteonectin/SPARC is overexpressed in human hepatocellular carcinoma.
Le Bail B; Faouzi S; Boussarie L; Guirouilh J; Blanc JF; Carles J; Bioulac-Sage P; Balabaud C; Rosenbaum J
J Pathol; 1999 Sep; 189(1):46-52. PubMed ID: 10451487
[TBL] [Abstract][Full Text] [Related]
19. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
Tátrai P
Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
[TBL] [Abstract][Full Text] [Related]
20. Rapid induction of PC3/BTG2 gene by hepatopoietin or partial hepatectomy and its mRNA expression in hepatocellular carcinoma.
Zhang ZM; Wang G; Chen C; Yang ZX; Jin F; San JL; Xu W; Li Q; Li ZP; Wang D
Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):288-93. PubMed ID: 19502170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]